Dzintars Gotham
Overview
Explore the profile of Dzintars Gotham including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
413
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Malhotra S, Cameron A, Gotham D, Burrone E, Gardner P, Loynachan C, et al.
PLOS Glob Public Health
. 2024 Jul;
4(7):e0003418.
PMID: 38950021
Monoclonal antibodies (mAbs) are revolutionizing management of non-communicable diseases in high-income countries and are increasingly being advanced for a range of infectious diseases (IDs). However, access to existing mAbs is...
2.
Barber M, Gotham D, Bygrave H, Cepuch C
JAMA Netw Open
. 2024 Mar;
7(3):e243474.
PMID: 38536176
Importance: The burden of diabetes is growing worldwide. The costs associated with diabetes put substantial pressure on patients and health budgets, especially in low- and middle-income countries. The prices of...
3.
Kadyrova N, Gotham D, Kniazkov S, Aghayev E, Hajibalayev P, Ermatov Z, et al.
PLoS One
. 2023 Dec;
18(12):e0294680.
PMID: 38060531
Background: Access to medicines is a global priority. Azerbaijan, Georgia, and Uzbekistan have different approaches to pricing policies for pharmaceuticals. The aim of this study was to analyze recent trends...
4.
Karduck L, Behnke A, Baier A, Gotham D, Grabitz P, Lennartz N, et al.
PLoS One
. 2022 Jan;
17(1):e0263556.
PMID: 35100300
[This corrects the article DOI: 10.1371/journal.pone.0231302.].
5.
Gotham D, McKenna L, Deborggraeve S, Madoori S, Branigan D
PLoS One
. 2021 Aug;
16(8):e0256883.
PMID: 34464413
Background: The GeneXpert diagnostic platform from the US based company Cepheid is an automated molecular diagnostic device that performs sample preparation and pathogen detection within a single cartridge-based assay. GeneXpert...
6.
Godman B, Hill A, Simoens S, Selke G, Krulichova I, Dias C, et al.
Expert Rev Pharmacoecon Outcomes Res
. 2021 Feb;
21(4):527-540.
PMID: 33535841
: There are growing concerns among European health authorities regarding increasing prices for new cancer medicines, prices not necessarily linked to health gain and the implications for the sustainability of...
7.
Gotham D, Moja L, van der Heijden M, Paulin S, Smith I, Beyer P
Health Policy
. 2021 Jan;
125(3):296-306.
PMID: 33402265
Introduction: The pipeline of new antibacterials remains limited. Reasons include low research investments, limited commercial prospects, and scientific challenges. To complement existing initiatives such as research grants, governments are exploring...
8.
Barber M, Gotham D, Khwairakpam G, Hill A
J Virus Erad
. 2020 Nov;
6(3):100001.
PMID: 33251019
Objectives: Seven years after the introduction of direct-acting antivirals (DAAs) for the treatment of hepatitis C, high prices remain a barrier for treatment programs worldwide. This study seeks to describe...
9.
Pilkington V, Hughes S, Pepperrell T, Mccann K, Gotham D, Pozniak A, et al.
AIDS
. 2020 Oct;
34(15):2259-2268.
PMID: 33048869
Background: Both tenofovir disoproxil fumarate (TDF)/emtricitabine and tenofovir alafenamide (TAF)/emtricitabine demonstrate excellent efficacy and safety overall, but concerns remain over specific changes in markers of bone and renal function. Lower...
10.
Gotham D, McKenna L, Frick M, Lessem E
PLoS One
. 2020 Sep;
15(9):e0239118.
PMID: 32946474
Introduction: In 2012, bedaquiline became the first new treatment from a novel class to be approved for tuberculosis in nearly five decades and is now a core component of the...